使用CRISPR-Cas9系统生成一个RIP1淘汰U937细胞系
Matthew A Deragon1, H John Sharifi2, Timothy J LaRocca3
1Department of Life Sciences, Albany College of Pharmacy and Health Sciences.
Journal of visualized experiments : JoVE
|April 28, 2025
概括
研究人员开发了一种CRISPR/Cas9方法,以淘汰U937细胞中的RIP1基因,在诱导亡后显著减少细胞死亡和线粒体反应性氧物种 (ROS).
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 受体相互作用蛋白激酶1 (RIP1) 是编程细胞死亡途径的关键调解者,包括亡.
- 了解RIP1的作用需要强大的遗传工具来产生功能性研究的淘汰细胞系.
研究的目的:
- 在人类单细胞U937细胞系中建立可靠的CRISPR/Cas9协议用于RIP1基因淘汰.
- 为了验证RIP1损失对细胞死亡和线粒体活动的功能后果.
主要方法:
- 利用CRISPR/Cas9技术与特定导向RNA和lentiviral载体用于U937细胞中的基因编辑.
- 进行了亡诱导试验并测量了细胞活力.
- 使用光显微镜评估线粒体的活性氧物种 (ROS) 生产.
主要成果:
- 成功生成了具有RIP1基因淘汰的U937细胞,通过功能测试证实了这一点.
- 在RIP1淘汰赛细胞中,在诱导亡时显著减少细胞死亡.
- 淘汰赛细胞在死细胞条件下显示线粒体ROS生成减少.
结论:
- 开发的CRISPR/Cas9协议有效地使U937细胞中的RIP1基因失活.
- 失去 RIP1 功能,使其对死细胞灭绝产生抗性,并降低了与此相关的线粒体 ROS 生产.
- 这种方法为研究RIP1介导的细胞死亡提供了有价值的工具,并且可以适应其他细胞死亡调节剂.
相关概念视频
CRISPR
46.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
46.4K
CRISPR/Cas9 Genome Editing
3.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.1K


